Medcorp Limited (TTSE:MED)
Trinidad and Tobago
· Delayed Price · Currency is TTD 45.00
0.00 (0.00%)
At close: Mar 5, 2026
Medcorp Income Statement
Financials in millions TTD. Fiscal year is January - December.
Millions TTD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 121.16 | 122.24 | 127.02 | 122.22 | 114.19 | 103.38 |
| Revenue Growth (YoY) | -4.61% | -3.76% | 3.92% | 7.03% | 10.46% | - |
| Cost of Revenue | 62.97 | 59.68 | 56 | 61.81 | 56.05 | 60.89 |
| Gross Profit | 58.19 | 62.55 | 71.02 | 60.41 | 58.14 | 42.49 |
| Selling, General & Admin | 37.62 | 38.64 | 33.24 | 32.08 | 28.4 | 25.64 |
| Other Operating Expenses | -1.07 | 0.55 | -1.66 | -3.19 | -5.25 | -6.01 |
| Operating Expenses | 36.55 | 39.19 | 31.59 | 28.89 | 23.15 | 19.63 |
| Operating Income | 21.64 | 23.36 | 39.43 | 31.52 | 34.99 | 22.86 |
| Interest Expense | -6.15 | -5.95 | -3.21 | -2.45 | -2.31 | -2.22 |
| Interest & Investment Income | 2 | - | 30.69 | - | - | - |
| Earnings From Equity Investments | 4.62 | 4.83 | 4.98 | 1.72 | 1.99 | 3.65 |
| EBT Excluding Unusual Items | 22.11 | 22.24 | 71.89 | 30.79 | 34.66 | 24.28 |
| Gain (Loss) on Sale of Assets | - | - | -0 | 0.12 | - | - |
| Other Unusual Items | 25.93 | 25.93 | - | - | - | - |
| Pretax Income | 48.04 | 48.17 | 71.89 | 30.91 | 34.66 | 24.28 |
| Income Tax Expense | 2.69 | 6.86 | 14.82 | 6.78 | 10.17 | 6.63 |
| Net Income | 45.35 | 41.31 | 57.07 | 24.13 | 24.49 | 17.65 |
| Net Income to Common | 45.35 | 41.31 | 57.07 | 24.13 | 24.49 | 17.65 |
| Net Income Growth | -20.53% | -27.62% | 136.53% | -1.49% | 38.74% | - |
| Shares Outstanding (Basic) | 8 | 7 | 7 | 7 | 7 | - |
| Shares Outstanding (Diluted) | 8 | 7 | 7 | 7 | 7 | - |
| EPS (Basic) | 5.79 | 5.52 | 7.63 | 3.23 | 3.27 | - |
| EPS (Diluted) | 5.79 | 5.52 | 7.63 | 3.23 | 3.27 | - |
| EPS Growth | -24.15% | -27.62% | 136.53% | -1.49% | - | - |
| Free Cash Flow | 38.46 | 20.12 | 28.71 | 25.41 | 5.66 | 19.77 |
| Free Cash Flow Per Share | 4.91 | 2.69 | 3.84 | 3.40 | 0.76 | - |
| Dividend Per Share | 5.000 | 4.000 | - | - | 4.500 | - |
| Gross Margin | 48.03% | 51.17% | 55.92% | 49.43% | 50.91% | 41.10% |
| Operating Margin | 17.86% | 19.11% | 31.05% | 25.79% | 30.64% | 22.11% |
| Profit Margin | 37.43% | 33.79% | 44.93% | 19.74% | 21.45% | 17.08% |
| Free Cash Flow Margin | 31.74% | 16.46% | 22.60% | 20.79% | 4.96% | 19.13% |
| EBITDA | 28.11 | 28.55 | 44.62 | 36.67 | 36.91 | 31.21 |
| EBITDA Margin | 23.20% | 23.36% | 35.13% | 30.00% | 32.32% | 30.19% |
| D&A For EBITDA | 6.47 | 5.19 | 5.18 | 5.14 | 1.92 | 8.35 |
| EBIT | 21.64 | 23.36 | 39.43 | 31.52 | 34.99 | 22.86 |
| EBIT Margin | 17.86% | 19.11% | 31.05% | 25.79% | 30.64% | 22.11% |
| Effective Tax Rate | 5.59% | 14.25% | 20.62% | 21.94% | 29.34% | 27.30% |
| Advertising Expenses | - | 0.24 | 0.17 | 0.2 | 0.14 | 0.31 |
Source: S&P Capital IQ. Standard template. Financial Sources.